D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| 1 |
Gilead Sciences
GILD
|
+$439M |
| 2 |
DTV
DIRECTV COM STK (DE)
DTV
|
+$391M |
| 3 |
Chevron
CVX
|
+$368M |
| 4 |
Williams Companies
WMB
|
+$334M |
| 5 |
Schlumberger
SLB
|
+$255M |
Top Sells
| 1 |
SPDR S&P 500 ETF Trust
SPY
|
+$469M |
| 2 |
Meta Platforms (Facebook)
META
|
+$376M |
| 3 |
Biogen
BIIB
|
+$308M |
| 4 |
Netflix
NFLX
|
+$307M |
| 5 |
Bausch Health
BHC
|
+$298M |
Sector Composition
| 1 | Energy | 14.62% |
| 2 | Technology | 12.08% |
| 3 | Healthcare | 11.47% |
| 4 | Consumer Discretionary | 11.26% |
| 5 | Industrials | 9.36% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
RC
2276
Ready Capital
RC
$675M
| $333K | ﹤0.01% |
20,589
-36,658
| -64% | -$593K |
|
|
GNMK
2277
DELISTED
GenMark Diagnostics, Inc
GNMK
| $333K | ﹤0.01% |
36,719
-3,523
| -9% | -$32K |
|
|
SPPI
2278
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
| $330K | ﹤0.01% |
48,209
-31,682
| -40% | -$217K |
|
|
CNXR
2279
DELISTED
Connecture, Inc.
CNXR
| $329K | ﹤0.01% |
31,113
-20,108
| -39% | -$213K |
|
2280
ODP
ODP
$611M
| $328K | ﹤0.01% |
+3,782
| New | +$328K |
|
|
EARN
2281
Ellington Residential Mortgage REIT
EARN
$213M
| $327K | ﹤0.01% |
22,922
+10,752
| +88% | +$153K |
|
2282
SFL Corp
SFL
$1.09B
| $327K | ﹤0.01% |
+20,062
| New | +$327K |
|
|
AFOP
2283
DELISTED
ALLIANCE FIBER OPTIC PROD INC COM STK
AFOP
| $327K | ﹤0.01% |
+17,648
| New | +$327K |
|
|
ACOR
2284
DELISTED
Acorda Therapeutics, Inc.
ACOR
| $326K | ﹤0.01% |
82
-122
| -60% | -$485K |
|
|
OMN
2285
DELISTED
OMNOVA Solutions Inc.
OMN
| $326K | ﹤0.01% |
43,560
-21,234
| -33% | -$159K |
|
|
MXPT
2286
DELISTED
MaxPoint Interactive, Inc.
MXPT
| $326K | ﹤0.01% |
+10,075
| New | +$326K |
|
2287
Sturm, Ruger & Co
RGR
$587M
| $325K | ﹤0.01% |
5,663
-48,359
| -90% | -$2.78M |
|
|
COBZ
2288
DELISTED
CoBiz Financial,Inc
COBZ
| $322K | ﹤0.01% |
24,669
+7,339
| +42% | +$95.8K |
|
|
ATRS
2289
DELISTED
Antares Pharma, Inc.
ATRS
| $319K | ﹤0.01% |
153,337
+18,828
| +14% | +$39.2K |
|
|
PSUN
2290
DELISTED
PACIFIC SUNWEAR OF CAL. INC
PSUN
| $319K | ﹤0.01% |
280,205
+2,311
| +0.8% | +$2.63K |
|
2291
Winmark
WINA
$1.76B
| $318K | ﹤0.01% |
3,226
-199
| -6% | -$19.6K |
|
|
BIOL
2292
DELISTED
Biolase, Inc.
BIOL
| $315K | ﹤0.01% |
15
+1
| +7% | +$21K |
|
|
USAK
2293
DELISTED
USA Truck Inc
USAK
| $315K | ﹤0.01% |
14,844
-1,956
| -12% | -$41.5K |
|
|
ZU
2294
DELISTED
ZULILY INC CLASS A COMMON STOCK
ZU
| $314K | ﹤0.01% |
24,110
+11,491
| +91% | +$150K |
|
|
CEL
2295
DELISTED
Cellcom Israel, Ltd.
CEL
| $313K | ﹤0.01% |
81,859
+11,194
| +16% | +$42.8K |
|
|
FMER
2296
DELISTED
FIRSTMERIT CORP
FMER
| $312K | ﹤0.01% |
+15,001
| New | +$312K |
|
2297
MasTec
MTZ
$15B
| $311K | ﹤0.01% |
15,650
-322,529
| -95% | -$6.41M |
|
|
SZYM
2298
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
| $311K | ﹤0.01% |
99,053
-129,896
| -57% | -$408K |
|
|
MOMO
2299
Hello Group
MOMO
$1.22B
| $310K | ﹤0.01% |
19,259
+83
| +0.4% | +$1.34K |
|
2300
Stoneridge
SRI
$229M
| $310K | ﹤0.01% |
26,462
-1,205
| -4% | -$14.1K |
|